VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 106 filers reported holding VIRIDIAN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $90,000 | +18.4% | 5,868 | +83.4% | 0.00% | – |
Q2 2023 | $76,000 | +40.7% | 3,199 | +48.8% | 0.00% | – |
Q1 2023 | $54,000 | -56.5% | 2,150 | -49.7% | 0.00% | – |
Q4 2022 | $124,000 | +1671.4% | 4,273 | +1222.9% | 0.00% | – |
Q3 2022 | $7,000 | +250.0% | 323 | +121.2% | 0.00% | – |
Q2 2022 | $2,000 | -98.4% | 146 | -97.9% | 0.00% | – |
Q1 2022 | $128,000 | – | 6,937 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VR Adviser, LLC | 2,699,865 | $78,863,057 | 13.28% |
COMMODORE CAPITAL LP | 2,020,166 | $59,009 | 8.89% |
ACUTA CAPITAL PARTNERS, LLC | 396,500 | $11,581,765 | 7.13% |
Fairmount Funds Management LLC | 1,369,623 | $40,006,688 | 6.35% |
Paradigm Biocapital Advisors LP | 1,751,167 | $51,151,588 | 6.00% |
Vivo Capital, LLC | 1,678,207 | $49,020 | 5.64% |
TCG Crossover Management, LLC | 983,610 | $28,731,248 | 5.07% |
Kynam Capital Management, LP | 1,034,697 | $30,223,499 | 4.64% |
Octagon Capital Advisors LP | 824,200 | $24,074,882 | 3.75% |
Logos Global Management LP | 1,000,000 | $29,210,000 | 3.42% |